Riehen
Switzerland
22
2024-11-21
The entities that hold a legal rights for patent applications filed by inventor Wartmann Markus:
Markus Wartmann from Riehen, CH has applied for patents for these inventions. The list has both pending applications and granted patents:
BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER
#2 | 2021-09-30Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors
#3 | 2018-03-08Pharmaceutical combinations
#4 | 2016-04-07COMBINATION THERAPY CONTAINING A PI3K-ALPHA INHIBITOR AND FGFR KINASE INHIBITOR FOR TREATING CANCER
#5 | 2012-11-08Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.
#6 | 2011-10-20Combinations of Therapeutic Agents for Treating Cancer
#7 | 2011-02-10COMBINATIONS COMPRISING EPOTHILONES AND PHARMACEUTICAL USES THEREOF
#8 | 2010-07-08COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
#9 | 2010-05-25Combination comprising a signal transduction inhibitor and an epothilone derivative
#10 | 2010-03-04Tubulin Mutation Diagnostic
#11 | 2009-12-24Combinations comprising epothilones and pharmaceutical uses thereof
#12 | 2009-08-13COMBINATION COMPRISING N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2-METHYLPHENYL)-4-(3-PYRIDYL)-2PYRIMIDINE-AMINE AND A CHEMOTHERAPEUTIC AGENT
#13 | 2009-07-30EPOTHILONE COMPOSITIONS
#14 | 2009-03-12CANCER TREATMENT WITH EPOTHILONES
#15 | 2008-06-05Tubulin Mutation Diagnostic
#16 | 2008-05-22Combinations comprising epothilones and pharmaceutical uses thereof
#17 | 2007-06-14Epothilone resistant cell lines
#18 | 2006-10-19Cancer treatment with epothilones
#19 | 2006-10-05Cancer treatment with epothilones
#20 | 2005-10-13Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors
#21 | 2005-07-28Cancer treatment with epothilones
#22 | 2005-02-24Epothilone compositions
1492809 ⎘